NASDAQ: IPA
Immunoprecise Antibodies Ltd Stock Ownership - Who owns Immunoprecise Antibodies?

Insider buying vs selling

Have Immunoprecise Antibodies Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPA insiders and whales buy or sell their stock.

IPA Shareholders

What type of owners hold Immunoprecise Antibodies Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ingalls Snyder LLC8.40%2,758,127$4.08MInstitution
Susquehanna International Group LLP2.14%703,000$1.04MInstitution
Two Sigma Investments LP0.28%90,582$134.06kInstitution
Virtu Financial LLC0.18%57,847$85.61kInstitution
Cibc World Market Inc0.13%41,200$60.98kInstitution
Thoroughbred Financial Services LLC0.12%40,000$59.20kInstitution
Group One Trading LLC0.09%30,061$44.49kInstitution
Renaissance Technologies LLC0.09%29,400$43.51kInstitution
Gradient Capital Advisors LLC0.08%26,808$39.68kInstitution
Federation Des Caisses Desjardins Du Quebec0.08%24,993$36.99kInstitution

1 of 3

IPA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPA11.97%0.00%
FBRX45.00%55.00%Net BuyingNet Selling
STRO73.02%18.21%Net SellingNet Selling
ACET67.53%19.44%Net Selling
CNTX79.60%1.46%Net BuyingNet Buying

Immunoprecise Antibodies Stock Ownership FAQ

Who owns Immunoprecise Antibodies?

Immunoprecise Antibodies (NASDAQ: IPA) is owned by 11.97% institutional shareholders, 0.00% Immunoprecise Antibodies insiders, and 88.03% retail investors. Ingalls Snyder LLC is the largest individual Immunoprecise Antibodies shareholder, owning 2.76M shares representing 8.40% of the company. Ingalls Snyder LLC's Immunoprecise Antibodies shares are currently valued at $5.46M.

If you're new to stock investing, here's how to buy Immunoprecise Antibodies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.